PEAK6 Investments’s Editas Medicine EDIT Stock Holding History

PEAK6 Investments’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$342K	Sell	100,200 -62,100	-38%	-$270K	﹤0.01%	2527
2024 Q2	$758K	Buy	162,300 +100,200	+161%	+$565K	﹤0.01%	2018
2024 Q1	$461K	Buy	+62,100	New	+$516K	﹤0.01%	2500
2023 Q4	–	Sell	-18,800	Closed	-$147K	–	4365
2023 Q3	$147K	Buy	18,800 +100	+0.5%	+$858	﹤0.01%	3227
2023 Q2	$154K	Buy	+18,700	New	+$163K	﹤0.01%	3022
2022 Q3	–	Sell	-18,700	Closed	-$154K	–	5222
2022 Q2	$154K	Sell	18,700 -6,700	-26%	-$89.8K	﹤0.01%	4957
2022 Q1	$483K	Buy	+25,400	New	+$472K	﹤0.01%	3175
2021 Q3	–	Sell	-30,100	Closed	-$1.71M	–	5290
2021 Q2	$1.71M	Buy	+30,100	New	+$1.11M	﹤0.01%	2056
2021 Q1	–	Sell	-30,200	Closed	-$2.12M	–	4983
2020 Q4	$2.12M	Buy	+30,200	New	+$1.24M	﹤0.01%	1799

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Investments's EDIT Position: Q3 2024 in Review

PEAK6 Investments reduced its Editas Medicine (EDIT) stake by 36% in Q3 2024, selling an estimated $163K and leaving 67,010 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #2719.

PEAK6 Investments first reported a position in EDIT in Q3 2021 and has held it in 9 quarters since. The position peaked at $488K in Q2 2024. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

PEAK6 Investments held 67,010 shares of Editas Medicine worth $229K as of Q3 2024.
PEAK6 Investments sold 37,500 Editas Medicine shares in Q3 2024, an estimated $163K.
Editas Medicine made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2719 holding.
PEAK6 Investments first reported a position in Editas Medicine in Q3 2021 and has held it in 9 quarters since.
PEAK6 Investments's Editas Medicine position peaked at $488K in Q2 2024.
229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.